Literature DB >> 16088560

Computed tomographic scanning in sarcoidosis.

Joseph P Lynch1.   

Abstract

Sarcoidosis is a granulomatous disease of unknown etiology that involves the lungs or intrathoracic lymph nodes in more than 90% of patients. The clinical spectrum of sarcoidosis is protean, but pulmonary manifestations often dominate. Chest radiographs are abnormal in 90 to 95% of patients with sarcoidosis; the most characteristic feature is bilateral hilar lymphadenopathy (BHL), present in 50 to 80% of patients. Pulmonary parenchymal infiltrates are present in 25 to 50% of patients. In this article, we review the radiographic features of sarcoidosis (both typical and atypical), and the impact of chest radiographic stage on long-term prognosis. Computed tomographic (CT) scans are more sensitive than chest radiographs in delineating parenchymal, mediastinal, and hilar structures, and distinctive CT patterns may be virtually pathognomonic for sarcoidosis in some patients. Routine CT scan is not appropriate to diagnose or manage sarcoidosis, but CT may be invaluable in patients with atypical clinical or chest radiographic findings or specific complications of sarcoidosis (pulmonary or extrapulmonary), or to assess prognosis. High-resolution thin-section CT scans (HRCT) may be helpful in selected patients with stage II or III sarcoidosis to discriminate active inflammation from irreversible fibrosis. This article discusses the salient HRCT features of sarcoidosis, accuracy of CT in the differential diagnosis, and correlations of HRCT with disease extent and activity, pulmonary function, and lesion reversibility.

Entities:  

Year:  2003        PMID: 16088560     DOI: 10.1055/s-2003-42375

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  12 in total

Review 1.  [Sarcoidosis].

Authors:  A Prasse; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

2.  [Its not always due to mumps!].

Authors:  C Brockmann; T Wilhelm; C Barth; K Hörmann; S O Schoenberg; C Fink
Journal:  Radiologe       Date:  2009-04       Impact factor: 0.635

3.  Radiomic measures from chest high-resolution computed tomography associated with lung function in sarcoidosis.

Authors:  Sarah M Ryan; Tasha E Fingerlin; Margaret Mroz; Briana Barkes; Nabeel Hamzeh; Lisa A Maier; Nichole E Carlson
Journal:  Eur Respir J       Date:  2019-08-29       Impact factor: 16.671

Review 4.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

5.  Automated quantification of high-resolution CT scan findings in individuals at risk for pulmonary fibrosis.

Authors:  Ivan O Rosas; Jianhua Yao; Nilo A Avila; Catherine K Chow; William A Gahl; Bernadette R Gochuico
Journal:  Chest       Date:  2011-05-26       Impact factor: 9.410

6.  Prolonged fever, dyspnoea and diffuse pleural thickening in a 20-year-old man.

Authors:  C Cai; D R Li; Q S Zeng; S Q Zhong; N S Zhong
Journal:  BMJ Case Rep       Date:  2009-05-10

7.  Mediastinal widening and miliary chest radiograph pattern in a middle aged man: could it be sarcoidosis?

Authors:  Clementine Bostantzoglou; Konstantinos Samitas; Charalampos Gkogkou; Eleftherios Zervas; Mina Gaga
Journal:  BMJ Case Rep       Date:  2014-07-17

8.  Ocular Manifestations of Biopsy-Proven Pulmonary Sarcoidosis in Korea.

Authors:  Seung Yong Choi; Jae Hoon Lee; Jae-Yon Won; Jeong Ah Shin; Young-Hoon Park
Journal:  J Ophthalmol       Date:  2018-02-11       Impact factor: 1.909

9.  HRCT findings of pulmonary sarcoidosis; relation to pulmonary function tests.

Authors:  Fatih Ors; Seyfettin Gumus; Mehmet Aydogan; Sebahattin Sari; Samet Verim; Omer Deniz
Journal:  Multidiscip Respir Med       Date:  2013-02-05

10.  Admixture fine-mapping in African Americans implicates XAF1 as a possible sarcoidosis risk gene.

Authors:  Albert M Levin; Michael C Iannuzzi; Courtney G Montgomery; Sheri Trudeau; Indrani Datta; Indra Adrianto; Dhananjay A Chitale; Paul McKeigue; Benjamin A Rybicki
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.